Clinical Trial Update: A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

View source ↗

Summary

This document describes a multicenter treatment protocol evaluating the combination of daclatasvir and sofosbuvir in post-liver transplant patients with chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis C | Status: NO_LONGER_AVAILABLE